Skip to main content
Journal cover image

Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901

Publication ,  Conference
Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Griffith, LM; Puck, J; Parikh, S; O'Reilly, RJ; Pai, S-Y; Hanson, IC; Martinez, C; Kohn, DB ...
Published in: Biology of Blood and Marrow Transplantation
February 2015

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S289 / S291

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heimall, J., Logan, B. R., Cowan, M. J., Notarangelo, L. D., Griffith, L. M., Puck, J., … Buckley, R. H. (2015). Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. In Biology of Blood and Marrow Transplantation (Vol. 21, pp. S289–S291). Elsevier BV. https://doi.org/10.1016/j.bbmt.2014.11.459
Heimall, Jennifer, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Linda M. Griffith, Jennifer Puck, Suhag Parikh, et al. “Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901.” In Biology of Blood and Marrow Transplantation, 21:S289–91. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.459.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck J, et al. Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S289–91.
Heimall, Jennifer, et al. “Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901.” Biology of Blood and Marrow Transplantation, vol. 21, no. 2, Elsevier BV, 2015, pp. S289–91. Crossref, doi:10.1016/j.bbmt.2014.11.459.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck J, Parikh S, O’Reilly RJ, Pai S-Y, Hanson IC, Martinez C, Pulsipher MA, Kapoor N, Goldman F, Kletzel M, Filipovich L, Cuvellier G, Thakar M, Burroughs L, Knudsen A, Connelly JA, Quigg TC, Smith AR, Sullivan K, Loechelt BJ, Gillio AP, Haddad E, Kohn DB, Fleisher T, Shearer W, Dvorak CC, Buckley RH. Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S289–S291.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S289 / S291

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 1103 Clinical Sciences